MedTrace Logo

Tetracycline Versus Doxycycline for HP Rescue Therapy

NCT05018923 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 242

Last updated 2021-08-26

No results posted yet for this study

Summary

This randomized controlled clinical trial will evaluate the efficacy and safety of proton pump inhibitor, bismuth, metronidazole, and either tetracycline or doxycycline for Helicobacter pylori rescue treatment. The completion of this trial will expand new therapy for the treatment of Helicobacter pylori.

Conditions

  • Helicobacter Pylori Infection

Interventions

DRUG

Rabeprazole

20mg bid

DRUG

Bismuth potassium citrate

0.6g bid

DRUG

Metronidazole

0.4g qid

DRUG

Doxycycline

0.1g bid

DRUG

Tetracycline

0.5g qid

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Taotao Liu, MD · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-24
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05018923 on ClinicalTrials.gov